Clinical Trial

Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated Bacteremia

Study acronym: FEN-AUREUS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 27, 2024 (before its estimated November 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to determine retrospectively whether different patient clinical phenotypes (adults and children) develop Staphylococcus aureus bacteremia.The main questions it aims to answer qre: 1. Evaluate its reproducibility and correlation with mortality 2. Derive and validate a simplified probabilistic model for phenotype assignment 3. External validation of the simplified probabilistic phenotype assignment model found and its association with mortality and development of complicated bacteremia in a prospective cohort 4. Apply microbiological, biochemical and immunological techniques to explain the physiopathological and genetic mechanisms underlying the phenotypes.
Trial Details
NCT Number NCT06574399
Lead Sponsor Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Conditions Staphylococcus Aureus Bacteremia
Enrollment 1,000 participants
Start Date 2023-05-01
Primary Completion 2024-11-30 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-27